CN108186966A - A kind of composition for preventing or improving senile dementia and its application - Google Patents
A kind of composition for preventing or improving senile dementia and its application Download PDFInfo
- Publication number
- CN108186966A CN108186966A CN201810252992.5A CN201810252992A CN108186966A CN 108186966 A CN108186966 A CN 108186966A CN 201810252992 A CN201810252992 A CN 201810252992A CN 108186966 A CN108186966 A CN 108186966A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- composition
- senile dementia
- zinc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- 208000024827 Alzheimer disease Diseases 0.000 title claims abstract description 38
- 206010039966 Senile dementia Diseases 0.000 title claims abstract description 36
- 239000000843 powder Substances 0.000 claims abstract description 167
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 23
- 235000008434 ginseng Nutrition 0.000 claims abstract description 23
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 20
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 16
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 16
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 16
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 16
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 14
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 14
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 14
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 14
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 14
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 14
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 14
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 14
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 14
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 14
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 14
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 14
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 14
- 230000002265 prevention Effects 0.000 claims abstract description 13
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 12
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 12
- 241001165494 Rhodiola Species 0.000 claims abstract description 12
- 235000006533 astragalus Nutrition 0.000 claims abstract description 11
- 235000013312 flour Nutrition 0.000 claims abstract description 11
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 10
- 240000007049 Juglans regia Species 0.000 claims abstract description 10
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 10
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 10
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 10
- 235000020234 walnut Nutrition 0.000 claims abstract description 10
- 235000011034 Rubus glaucus Nutrition 0.000 claims abstract description 9
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract description 9
- 230000006872 improvement Effects 0.000 claims abstract description 9
- 240000007651 Rubus glaucus Species 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims description 36
- 229940079593 drug Drugs 0.000 claims description 28
- 240000004371 Panax ginseng Species 0.000 claims description 22
- 235000009508 confectionery Nutrition 0.000 claims description 13
- 239000011669 selenium Substances 0.000 claims description 13
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical group [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 11
- 239000011777 magnesium Substances 0.000 claims description 11
- 229910052749 magnesium Inorganic materials 0.000 claims description 11
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 10
- 230000036541 health Effects 0.000 claims description 10
- 229910052711 selenium Inorganic materials 0.000 claims description 10
- 229940091258 selenium supplement Drugs 0.000 claims description 10
- 239000011573 trace mineral Substances 0.000 claims description 10
- 235000013619 trace mineral Nutrition 0.000 claims description 10
- 239000011701 zinc Substances 0.000 claims description 10
- 229910052725 zinc Inorganic materials 0.000 claims description 10
- 230000012010 growth Effects 0.000 claims description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- -1 pulvis Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 235000013361 beverage Nutrition 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 239000004471 Glycine Substances 0.000 claims description 3
- 235000002789 Panax ginseng Nutrition 0.000 claims description 3
- 240000005373 Panax quinquefolius Species 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 102000008114 Selenoproteins Human genes 0.000 claims description 3
- 108010074686 Selenoproteins Proteins 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 3
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 3
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000011781 sodium selenite Substances 0.000 claims description 3
- 229960001471 sodium selenite Drugs 0.000 claims description 3
- 235000015921 sodium selenite Nutrition 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 235000019640 taste Nutrition 0.000 claims description 3
- 239000011670 zinc gluconate Substances 0.000 claims description 3
- 235000011478 zinc gluconate Nutrition 0.000 claims description 3
- 229960000306 zinc gluconate Drugs 0.000 claims description 3
- 239000011576 zinc lactate Substances 0.000 claims description 3
- 235000000193 zinc lactate Nutrition 0.000 claims description 3
- 229940050168 zinc lactate Drugs 0.000 claims description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 3
- 229960001763 zinc sulfate Drugs 0.000 claims description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 3
- 235000015895 biscuits Nutrition 0.000 claims description 2
- 229960002449 glycine Drugs 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 235000015110 jellies Nutrition 0.000 claims description 2
- 239000008274 jelly Substances 0.000 claims description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 2
- 235000013618 yogurt Nutrition 0.000 claims description 2
- 239000011746 zinc citrate Substances 0.000 claims description 2
- 235000006076 zinc citrate Nutrition 0.000 claims description 2
- 229940068475 zinc citrate Drugs 0.000 claims description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical group CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 claims 2
- 150000003254 radicals Chemical class 0.000 abstract description 12
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 235000019614 sour taste Nutrition 0.000 abstract description 3
- 235000019605 sweet taste sensations Nutrition 0.000 abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 24
- 210000004369 blood Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 210000003734 kidney Anatomy 0.000 description 17
- 238000002156 mixing Methods 0.000 description 17
- 238000003304 gavage Methods 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 210000004072 lung Anatomy 0.000 description 14
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 230000007812 deficiency Effects 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 230000004083 survival effect Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000032683 aging Effects 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 238000012549 training Methods 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000009191 jumping Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000015654 memory Effects 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 241000218231 Moraceae Species 0.000 description 4
- 235000008708 Morus alba Nutrition 0.000 description 4
- 240000006079 Schisandra chinensis Species 0.000 description 4
- 235000008422 Schisandra chinensis Nutrition 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 235000002722 Dioscorea batatas Nutrition 0.000 description 3
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 3
- 240000001811 Dioscorea oppositifolia Species 0.000 description 3
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 240000002853 Nelumbo nucifera Species 0.000 description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 235000018167 Reynoutria japonica Nutrition 0.000 description 3
- 240000001341 Reynoutria japonica Species 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000009189 diving Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000005787 Cistanche Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241001074093 Echinopsis Species 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241000361919 Metaphire sieboldi Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- GMZVRMREEHBGGF-UHFFFAOYSA-N Piracetam Chemical compound NC(=O)CN1CCCC1=O GMZVRMREEHBGGF-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 244000197580 Poria cocos Species 0.000 description 2
- 235000008599 Poria cocos Nutrition 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 244000235659 Rubus idaeus Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 244000126002 Ziziphus vulgaris Species 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 229940099690 malic acid Drugs 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000006386 memory function Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229960004526 piracetam Drugs 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- PKXWXXPNHIWQHW-RCBQFDQVSA-N (2S)-2-hydroxy-3-methyl-N-[(2S)-1-[[(5S)-3-methyl-4-oxo-2,5-dihydro-1H-3-benzazepin-5-yl]amino]-1-oxopropan-2-yl]butanamide Chemical compound C1CN(C)C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](O)C(C)C)C2=CC=CC=C21 PKXWXXPNHIWQHW-RCBQFDQVSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229940100578 Acetylcholinesterase inhibitor Drugs 0.000 description 1
- 235000013073 Acorus gramineus Nutrition 0.000 description 1
- 244000001632 Acorus gramineus Species 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- 235000006487 Euryale ferox Nutrition 0.000 description 1
- 244000268590 Euryale ferox Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- FYSHYFPJBONYCQ-OLZOCXBDSA-N Gomisin K3 Natural products O(C)c1c(OC)c2-c3c(O)c(OC)c(OC)cc3C[C@@H](C)[C@@H](C)Cc2cc1OC FYSHYFPJBONYCQ-OLZOCXBDSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034719 Personality change Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 description 1
- 244000046095 Psophocarpus tetragonolobus Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- UNWAHVGSROASNT-HXNJGWPRSA-N amarolide Chemical compound C[C@H]1C(=O)[C@@H](O)[C@@H]2[C@@]3(C)C(=O)[C@@H](O)C[C@@H](C)[C@@H]3C[C@@H]3[C@@]2(C)[C@H]1CC(=O)O3 UNWAHVGSROASNT-HXNJGWPRSA-N 0.000 description 1
- UNWAHVGSROASNT-UHFFFAOYSA-N amarolide Natural products CC1C(=O)C(O)C2C3(C)C(=O)C(O)CC(C)C3CC3C2(C)C1CC(=O)O3 UNWAHVGSROASNT-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000544 cholinesterase inhibitor Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 210000004295 hippocampal neuron Anatomy 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 230000005056 memory consolidation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000003703 n methyl dextro aspartic acid receptor blocking agent Substances 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000002682 neurofibrillary tangle Anatomy 0.000 description 1
- 239000003176 neuroleptic agent Substances 0.000 description 1
- 230000000701 neuroleptic effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000004793 poor memory Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000013102 re-test Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- FYSHYFPJBONYCQ-QWHCGFSZSA-N schisanhenol Chemical compound C1[C@H](C)[C@H](C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2O FYSHYFPJBONYCQ-QWHCGFSZSA-N 0.000 description 1
- FYSHYFPJBONYCQ-UHFFFAOYSA-N schisanhenol Natural products C1C(C)C(C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2O FYSHYFPJBONYCQ-UHFFFAOYSA-N 0.000 description 1
- 229930193195 schizandrin Natural products 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- HSTCACQRSLZQHZ-UHFFFAOYSA-N shinjulactone H Natural products CC1CC(O)C(=O)C2(C)C1CC3OC(=O)CC4C(C)C(O)C(=O)C2C34C HSTCACQRSLZQHZ-UHFFFAOYSA-N 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000003568 synaptosome Anatomy 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 108010084171 vanutide cridificar Proteins 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of composition for preventing or improving senile dementia and its applications, belong to Halth-care composition technical field.The composition includes following raw material by weight:25 parts of ginseng pulverate, 25 parts of Radix Notoginseng powder, 2 20 parts of hawthorn powder, 15 parts of wolfberry fruit powder, 15 parts of yam flour, 15 parts of Fructus Schisandrae Chinensis powder, 15 parts of Radix Polygalae powder, 0.2 4.0 parts of sorosis powder, 0.05 1.1 parts of gingko powder, 0.1 2.5 parts of kudzu-vine root powder, 0.1 2.5 parts of rhizoma alismatis powder, 0.1 2.5 parts of walnut powder, 0.2 1.6 parts of rhodiola root powder, 13 parts of astragalus membranaceus powder, 13 parts of raspberry powder, 13 parts of fructus alpiniae oxyphyllae powder, 5 15 parts of red date powder.The composition compatibility is scientific and reasonable, effectively prevent infringement of the free radical to human body, has prevention and improvement result well to senile dementia, and preparation method is simple, and production cost is low, carries convenient, sweet and sour taste.
Description
Technical field
The present invention relates to Halth-care composition technical fields, and in particular to a kind of combination prevented or improve senile dementia
Object and its application.
Background technology
Senile dementia or senile Alzheimer disease (Alzheimer ' s disease, AD) are worldwide old age
The common disease of people accounts for the 4th of human death's reason, is increasingly subject to the attention of society and national governments.AD is a kind of diffusivity
Nervous centralis degenerative disease, characterized by progressive cognitive disorder, intelelectual deterioration and personality change, with Cerebral Amyloid egg
White A β 1-42 depositions, neurofibrillary tangles, neuron loss and slow inflammatory pathologies.The cause of disease and pathogenesis of AD is still
Not fully aware of, there are many theory at present about senile dementia mechanism study, have acetylcholine shortage theory, proteins toxic to sink
Product theory, harmful free radicals damage theory etc..Clinically can behave as progressive impaired memory function, cognitive function it is disorderly and
Behavioral aspect changes.Especially AD lacks objective efficiency index before death.The drug for the treatment of senile dementia on the market does not have also at present
Reach highly satisfactory result.The drug for the treatment of AD mainly has (1) acetylcholine enzyme inhibitor (Acetyl at present
cholinesterase inhibitors,AChEIs);(2) nmda antagonist;(3) other Semagacestat
(LY450139), ACC-001, rush metabolic drug, non-steroidal anti-inflammatory drugs, antioxidant, neural blood vessel conditioning agent, estrin treatment
Deng.The effect of more than drug, sees generally.
Research work has made intensive studies the structure of Chinese medicine and pharmacodynamics etc. in recent years, finds many Chinese medicines and its carries
Take object, such as polysaccharides, astragalus polyose, ginsenoside that all there is good immunoregulation effect, the mechanism of action is substantially
By being carried to the adjusting of mononuclear macrophage, NK cells, T cell, B cell, cell factor and neuro-endocrine-immune network
High body resistance against diseases, achieve the purpose that prevent and cure diseases (Sun Wei wide etc., 2001).Chinese patent CN105561108A,
CN101797351A and CN97117052.5A etc. discloses the pharmaceutical composition of different several treatment senile dementias, these
The composition of composition is to include rhodiola root, akebi, the fleece-flower root, Herba Epimedii, ginseng, grass-leaved sweetflag, pueraria lobata, Rhizoma Chuanxiong etc., is made each
Kind peroral dosage form.Chinese patent CN200510002971.0A discloses a kind of Chinese medicine preparation for treating senile dementia, including
Following Chinese medicine material:Prepared fleece flower root is processed into clear cream by prepared fleece flower root, lotus leaf, Herba Cistanches, earthworm, Radix Rhapontici seu Radix Echinopsis;Lotus leaf, Herba Cistanches,
Radix Rhapontici seu Radix Echinopsis decocts extraction and clear cream is made;Dry cream is made in merging, and earthworm processing is made dry cream and merges again with aforementioned dry cream, and finished product is made.
Chinese patent CN02112711.5A discloses a kind of composition of prevention senile dementia being made of Poria cocos, Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis.
The Chinese herbal product of above-mentioned treatment senile dementia is focused on adjusting too much, and relative reduction plays the drug proportion of therapeutic effect,
Pharmic function performance is affected, so effect is slow, the course for the treatment of is long, and effect is less preferable.Chinese medicine is due to being mostly the decoction or ball boiled
Agent takes difficulty compared with Western medicine, has also greatly affected the popularization of Chinese medicine.
Invention content
For overcome the deficiencies in the prior art, prevent or improve senile dementia the purpose of the present invention is to provide a kind of
Composition and its application, the composition compatibility is scientific and reasonable, effectively prevent infringement of the free radical to human body, has to senile dementia
There are prevention and improvement result well, preparation method is simple, and production cost is low, carries convenient, sweet and sour taste.
To solve the above problems, the technical solution adopted in the present invention is as follows:
A kind of composition prevented or improve senile dementia, including following raw material by weight:Ginseng pulverate 2-5
Part, 2-5 parts of Radix Notoginseng powder, 2-20 parts of hawthorn powder, 1-5 parts of wolfberry fruit powder, 1-5 parts of yam flour, 1-5 parts of Fructus Schisandrae Chinensis powder, Radix Polygalae powder 1-5
Part, 0.2-4.0 parts of sorosis powder, 0.05-1.1 parts of gingko powder, 0.1-2.5 parts of kudzu-vine root powder, 0.1-2.5 parts of rhizoma alismatis powder, walnut powder
0.1-2.5 parts, 0.2-1.6 parts of rhodiola root powder, 1-3 parts of astragalus membranaceus powder, 1-3 parts of raspberry powder, 1-3 parts of fructus alpiniae oxyphyllae powder, red date powder 5-
15 parts.
As the preferred embodiment of the present invention, composition of the invention includes following raw material by weight:Ginseng
2-4 parts of powder, 2-3 parts of Radix Notoginseng powder, 3-16 parts of hawthorn powder, 2-5 parts of wolfberry fruit powder, 2-5 parts of yam flour, 2-5 parts of Fructus Schisandrae Chinensis powder, Radix Polygalae powder
2-5 parts, 0.4-3.0 parts of sorosis powder, 0.05-1.5 parts of gingko powder, 0.1-2.4 parts of kudzu-vine root powder, 0.1-2.4 parts of rhizoma alismatis powder, walnut powder
0.1-2.4 parts, it is 0.2-1.5 parts of rhodiola root powder, 1-2.5 parts of astragalus membranaceus powder, 1-2.5 parts of raspberry powder, 1-2.5 parts of fructus alpiniae oxyphyllae powder, red
5-10 parts of date powder.
As the preferred embodiment of the present invention, composition of the invention includes following raw material:Ginseng pulverate 2g, Radix Notoginseng powder
2g, hawthorn powder 8g, wolfberry fruit powder 5g, yam flour 3g, Fructus Schisandrae Chinensis powder 4g, Radix Polygalae powder 2g, sorosis powder 0.5g, gingko powder 0.06g, pueraria lobata
Powder 0.2g, rhizoma alismatis powder 0.4g, walnut powder 0.4g, rhodiola root powder 0.5g, astragalus membranaceus powder 1g, raspberry powder 1g, fructus alpiniae oxyphyllae powder 1g, jujube
Powder 9g.
In above-mentioned formula, the ginseng pulverate is wild ginseng, artificial growth ginseng, Korean ginseng or American Ginseng powder or its
Extract.
As the preferred embodiment of the present invention, composition of the invention further includes trace element, and the trace element is
Magnesium, zinc, selenium are respectively in the content of composition:0.01~0.5mg/g of magnesium, 0.01~0.2mg/g of zinc, selenium 0.01~
0.5mg/g。
It is further preferred that the magnesium is magnesium stearate, the zinc is zinc sulfate, zinc citrate, zinc lactate, glycine zine
Or one kind in zinc gluconate;The one kind of the selenium in sodium selenite, selenoprotein or Se-enriched yeast.
The present invention also provides the medicines that composition as described above has the function of to prevent or improve senile dementia in preparation
Application in product, health products, food.
Specifically, the drug is one kind in capsule, tablet, pulvis, granule or pill;The health products are solid
One kind in body beverage, tea bag, oral liquid or health liquor;The food is cake, biscuit, candy, Yoghourt, hawthorn item, jelly
Or one kind in mixed congee.
In above-mentioned formula, ginseng is the traditional rare Chinese medicine in China, belongs to Araliaceae herbaceous plant, has a variety of neural medicines
Reason activity such as changes brain alkaloid, the learning ability promoting learning and memory ability, promote fatigue recovery, improving humans and animals,
Enhance immunity of organisms.Water extracts from Ginseng has significant protective effect to the SH-SY5Y Apoptosis that amyloid beta induces,
Ginsenoside can be obviously prolonged animal lifespan and cell survival, and can remove the free radical for causing aging in vivo and biomembrane is protected to exempt from
It is damaged by free radical;Senile rat cardiac muscle, brain and liver tissues lipofuscin content are can obviously reduce, significantly reduces serum peroxidating
Lipid, and the activity of superoxide dismutase can be improved.
Radix Notoginseng, sweet and slightly bitter taste is warm-natured, return liver warp, stomach, the heart channel of Hang-Shaoyin, lung channel, large intestine channel.Radix Notoginseng can promote blood circulation,
It is often edible to reduce blood cholesterol and triglyceride, and hyperlipemia hypertension, apoplexy, angiocarpy etc. can be prevented
Disease.The active constituent of Radix Notoginseng be the total soap of Radix Notoginseng, there is dissipate stasis of blood hemostasis, detumescence ding-tong, it can also be used to treat hemoptysis,
It spits blood, have blood in stool, uterine bleeding, traumatic hemorrhage, chest and abdomen shouting pain, falling swelling and pain etc..With the development for medical research, it is found that Radix Notoginseng not only has
There are good hemostasis, promoting blood circulation and removing blood stasis, active two-way pharmacological action of promoting blood circulation, also with apparent blood tonification effect, can promote in blood
All kinds of blood cell merisis such as red blood cell, leucocyte, blood platelet increase number, keep the effect of normal level, have simultaneously
Have antithrombotic, protection cardiac muscle and prevent brain tissue impairment and expand blood vessel, increase brain and coronary blood flow, by blood fat, blood pressure lowering,
The multiple pharmacological effects such as analgesia, anti-inflammatory, elimination free radical.
Hawthorn, warm-natured, acid sweet in flavor, Return liver, spleen, stomach, promoting digestion and removing indigestion, promoting blood circulation to remove blood stasis, for meat stagnation, abdominal pain is let out
It rushes down, postpartum stasis, hernia pain, there is coronary artery dilator, vasodilator, blood fat-reducing blood pressure-decreasing cardiac stimulant.
Matrimony vine contains abundant polysaccharides, fat, protein, free amino acid, taurine, glycine betaine, vitamin
B1, B2, E, C, particularly carotenoid content are very high;Additionally contain a large amount of mineral element.Matrimony vine has enriching yin and nourishing kidney,
Brain tonic blood-nourishing, improving eyesight benefit god, anti-aging and other effects, are widely used in and adjust blood fat, resist oxygen lack, anti-oxidant, immunological regulation, benefit
Blood, anti-aging, improves stomach function, antifatigue, enhancing development, improves eyesight etc. the protection of chemical damage.
Chinese yam, mild-natured, sweet in flavor, returns spleen, lung, kidney channel, tonifying spleen nourishing the stomach, engender liquid and benefic lung, the puckery essence of kidney tonifying, for spleen eating less,
Endless diarrhea, the deficiency syndrome of the lung are breathed with cough, emission due to the kidney deficiency, and under band, frequent micturition, abnormal heat is quenched one's thirst.Chinese yam contains the objects such as amylase, polyphenol oxidase
Matter is conducive to taste digestion and absorption function;Chinese yam contains a large amount of mucus albumen, electrolytes and minerals, can effectively prevent
Blood fat has effects that beneficial will calms the nerves, promotes longevity in the precipitation of vascular wall and reduction blood glucose, prevention cardiovascular diseases.
Schisandra chinensis, it is sour warm-natured, enter lung channel, kidney channel, the heart channel of Hang-Shaoyin, for chronic cough and dyspnea of deficiency type, injury thirst, spontaneous sweating, kidney deficiency
Seminal emission, spleen kidney deficiency are rushed down, palpitation and insomnia.Schisandra chinensis is the dry mature fruit of magnoliaceae schisandra or schisandra chinensis,
Fruit contains schizandrin and vitamin C, resin, tannin and a small amount of carbohydrate;With astringe the lung to stop cough, nourish it is puckery essence, antidiarrheal hidroschesis it
Effect.
Radix Polygalae, slightly warm in nature, bitter, acrid flavour enter the heart channel of Hang-Shaoyin, lung channel, kidney channel, have the function of tranquilize the mind and promote the intelligence, eliminating the phlegm, detumescence,
For insomnia of palpitating with fear, dreaminess is forgetful, coma epilepsy, coughing with a lot of sputum, swollen ulcer drug.
Sorosis, it is sweet in flavor and cold in property, there is liver-kidney tonifying, ease constipation of promoting the production of body fluid, UFA eyesight and other effects, contain sugar, protein, fat
Fat, malic acid, malic acid and vitamin A, vitamin B1, vitamin B2, vitamin C, iron, sodium, calcium, magnesium, phosphorus, potassium, carrotene and
Anthocyanidin.The aliphatic acid of Fructus Mori oil is mainly made of linoleic acid and a small amount of stearic acid, oleic acid etc..Mulberries have improvement skin blood
Supply, nutrition skin make skin delicate and the effects that black hair, and can slow down aging.In addition, mulberries have effect of gain to spleen,
There is humidification to hemolytic reaction, human body artery hardening, skeletal joint hardening can be prevented, boost metabolism, promote blood red
The growth of cell prevents Neuroleptic Leukocytopenia, and to treatment diabetes, anaemia, hypertension, hyperlipidemia, coronary heart disease, neurasthenia etc.
Illness has effects that auxiliary.
Gingko, also known as ginkgo, it is sweet in flavor, bitter, puckery, it is mild-natured, it is slightly poisonous.Distributed in lung channel, kidney channel.Function:Astringing lung for relieving asthma, stop-band contracting
Urine;It cures mainly:Asthma phlegm is coughed, leukorrhea, gonorrhoea, seminal emission, frequent micturition, nameless sores or boils, Zha nose, tinea sore.Flavonoid glycoside in gingko benevolence and
Amarolide also has the diseases such as cerebral thrombus, senile dementia, hypertension, hyperlipidemia, coronary heart disease, artery sclerosis, Aging
There is special prevention and treatment effect.
Pueraria lobata, cool in nature, acrid-sweet flavor, returns spleen stomach.Principal solution flesh is brought down a fever, and is promoted the production of body fluid, promoting eruption, Shengyang Zhixie.Research shows that pueraria lobata
There is apparent therapeutic effect to learning memory disorder, available for treating the illnesss such as senile dementia, dysnoesia, poor memory.
Kudzu-vine root powder contains 12% flavone compound, such as Puerarin, daizeol glycosides, peanut element nutritional ingredient, also protein, ammonia
The minerals such as base acid, sugared and iron needed by human, calcium, copper, selenium.
Rhizoma alismatis, it is sweet in flavor, it is cold in nature, return kidney, bladder warp, have effects that clearing damp and promoting diuresis, expel the heat-evil it is treating stranguria.
Walnut, it is sweet in flavor, it is warm-natured, return kidney, lung, large intestine channel, there is replenishing kidney, strengthening waist, warm lung Dingchuan, relax bowel, use
In pain in the back flaccidity of lower limbs, long void syndrome characterized by dyspnea, dry constipation of intestines.
Rhodiola root, mild-natured, sweet in flavor, bitter, distributed in lung channel, the heart channel of Hang-Shaoyin has effects that qi and activate blood circulation, promotes blood circulation and relievings asthma, for the deficiency of vital energy
Blood stasis, chest impediment and cardialgia, hemiplegia, burnout asthma.
Radix Astragali, sweet in flavor, tepor, returns spleen, lung channel, have invigorating qi for consolidating superficies, tonifying Qi and lifting yang, promoting pus discharge and tissue regeneration, inducing diuresis for removing edema work(
Effect, for treatment deficiency of vital energy weak, anorexia and loose stool, the sinking of qi of middle-jiao, rush down prolapse of the anus for a long time, from juice night sweat, blood deficiency chlorosis, cloudy subcutaneous ulcer overflows swollen, deficiency of vital energy water
It is swollen, Heat Diabetes.
Raspberry, it is sweet in flavor, sour, it is warm-natured, return liver and kidney channel, there is astringent sperm contracting urine, kidney-nourishing nourishing the liver, for passing out semen, urine
Frequently, the enuresis, impotence.
Fructus alpiniae oxyphyllae, acrid flavour is warm-natured, returns spleen, kidney channel, has effects that warming spleen and stopping diarrha, warm kidney astringent sperm contracting urine, is spat for abdominal pain
It rushes down, the more salivas of deficiency of food, the enuresis of passing out semen.
Jujube, sweet in flavor nontoxic, main heart perverse trend support spleen in peace, and flat stomach gas leads to nine orifices, help 12 warps, embellish lung, and cough-relieving is mended
The five internal organs, governance wasting, except stomach addiction gas.Jujube contain protein, a variety of amino acid, carrotene, vitamin A, B2, C, P, irony,
Calcareous, phosphorus matter etc. is beneficial to liver.
In the mentioned component of the present invention, pueraria lobata and gingko can be by influencing the level of interior free yl and with excellent
Anti-free radical effects, and wolfberry fruit powder, red date powder and mulberries powder clear up free radical, slow down aging the effect of on kudzu-vine root powder
There is synergistic effect with gingko powder;This five tastes ingredient of gingko powder, mulberries powder, kudzu-vine root powder, yam flour, astragalus membranaceus powder is improving painstaking effort
Pipe enhances immune, promotion memory use with synergistic enhancing effect.In addition, gingko powder can influence Radical Metabolism, it is right
Gently, moderate dementia patient has significant effect;Schisanhenol has significantly brain synaptosome big caused by oxygen radical and mitochondria
Protective effect, available for slowing down aging, preventing senile dementia;Rhodiola essence can significantly improve the learning and memory barrier of dementia rats
Hinder, suppress denaturation and the apoptosis of hippocampal neuron, be conducive to radicals scavenging system and prevent AD.
Compared with prior art, the beneficial effects of the present invention are:
The present invention is that applicant is established in the mechanism of Chinese tradition integration of drinking and medicinal herbs and Central nervous system senile dementia
It is pathogenetic study for a long period of time on the basis of, with reference to a large amount of achievement in research of modern Chinese medicine pharmacy drug pharmacology both at home and abroad and
Documents and materials have consulted and can be used for the plant Chinese herbal medicine of food or vegetables and fruits class from the integration of drinking and medicinal herbs that tens kinds of Ministry of Public Health announce
Essence dry powder data is therefrom filtered out to removing free radical effectively with raising body immunity, the plant that can promote longevity
By the multiple Experimental comparison repeatedly of applicant research team, it is good to find out mouthfeel for class Chinese herbal medicine or vegetables and fruits class essence dry powder type
Delicious formula produces the composition that the suitable middle-aged and the old eats by the production method of industrialized standard, to prevention or
Improve senile dementia and obtain certain effect.
The composition of the present invention can restrain injury of the free radical to cell, safeguard the normal operation of human body various functions, increase
Strong muscle power, Eradicates disease health cares retain youthful vitality, and can keep fit and healthy, prevent old brain tonic, kidney tonifying enriching yin, adjust hormonal secretion, change
The function of kind the elderly's physiological metabolism, enhances memory of elderly person brain function, has prevention well to senile dementia and improves and makees
With, and convenient, sweet and sour taste is carried, meet the eating habit of the elderly.
Specific embodiment
The present invention is described in further detail With reference to embodiment.
A kind of composition prevented or improve senile dementia, including following raw material by weight:Ginseng pulverate 2-5
Part, 2-5 parts of Radix Notoginseng powder, 2-20 parts of hawthorn powder, 1-5 parts of wolfberry fruit powder, 1-5 parts of yam flour, 1-5 parts of Fructus Schisandrae Chinensis powder, Radix Polygalae powder 1-5
Part, 0.2-4.0 parts of sorosis powder, 0.05-1.1 parts of gingko powder, 0.1-2.5 parts of kudzu-vine root powder, 0.1-2.5 parts of rhizoma alismatis powder, walnut powder
0.1-2.5 parts, 0.2-1.6 parts of rhodiola root powder, 1-3 parts of astragalus membranaceus powder, 1-3 parts of raspberry powder, 1-3 parts of fructus alpiniae oxyphyllae powder, red date powder 5-
15 parts.
Wherein, ginseng pulverate is the powder or its extract of wild ginseng, artificial growth ginseng, Korean ginseng or American Ginseng.This
The composition of invention further includes trace element, and the trace element is magnesium, zinc, selenium, is respectively in the content of composition:Magnesium
0.01~0.5mg/g, 0.01~0.2mg/g of zinc, 0.01~0.5mg/g of selenium.Magnesium is magnesium stearate, and zinc is zinc sulfate, citric acid
One kind in zinc, zinc lactate, glycine zine or zinc gluconate;Selenium in sodium selenite, selenoprotein or Se-enriched yeast one
Kind.
Table 1 is applicant in the optimization formula obtained after repetitious experiment.
The component and its dosage that table 1 is respectively formulated
Composition | It is formulated a dosage (g) | It is formulated two dosages (g) | It is formulated three dosages (g) |
Ginseng pulverate | 2 | 1.5 | 1.2 |
Radix Notoginseng powder | 2 | 1.5 | 1.2 |
Hawthorn powder | 8 | 6 | 5 |
Wolfberry fruit powder | 5 | 5 | 4 |
Yam flour | 3 | 3 | 2 |
Fructus Schisandrae Chinensis powder | 4 | 3 | 3 |
Radix Polygalae powder | 2 | 2 | 3 |
Sorosis powder | 0.5 | 1.5 | 3 |
Gingko powder | 0.06 | 0.6 | 1 |
Kudzu-vine root powder | 0.2 | 1.2 | 2 |
Rhizoma alismatis powder | 0.4 | 1.4 | 2 |
Walnut powder | 0.4 | 1.4 | 2 |
Rhodiola root powder | 0.5 | 1 | 1.5 |
Astragalus membranaceus powder | 1 | 2 | 1.5 |
Raspberry powder | 1 | 2 | 1.5 |
Fructus alpiniae oxyphyllae powder | 1 | 2 | 1.5 |
Red date powder | 9 | 4 | 6 |
Altogether | 39.66 | 39.1 | 39.9 |
Embodiment 1:
By in table 1 formula one formula rate be configured to 100 kilograms of mixing powders, after mixing add in trace element after
Then medicinal preparation for oral administration is conventionally made in continuous mixing, dry sterilization, such as capsule, tablet, pulvis, particle, pill, Gu
Body beverage, tea bag.
Embodiment 2:
By in table 1 formula one formula rate be configured to 100 kilograms of mixing powders, after mixing add in trace element after
Then oral liquid or health care wine liquid is conventionally made in continuous mixing, dry sterilization.
Embodiment 3:
100kg mixing powders are configured in the ratio of formula two in table 1, trace element is added in after mixing and continues to mix
It is even, it is packed after dry sterilization, every bag of 150g, takes above-mentioned 1 bag of 150g mixed powder, be uniformly mixed with 1500g Self- raising flour, with suitable
Amount egg, milk, baking powder, sugar are made with the cake for preventing or improving senile dementia effect.
Embodiment 4:
100kg mixing powders are configured in the ratio of formula two in table 1, along with the Poria cocos of equivalent, Gorgon fruit, hyacinth bean, the heart of a lotus seed
Rice, lotus-seed kernel, glutinous rice, polished rice are ground into fine powder, add in trace element after mixing and continue mixing, pack, make after dry sterilization
Into health care powder or solid beverage, eaten for the middle-aged and the old.
Embodiment 5:
100kg mixing powders are configured in the ratio of formula three in table 1, along with the hawthorn powder of equivalent, mix, cook,
Mashing, molding, drying, packaging, are made with the hawthorn item for preventing or improving senile dementia effect.
Compliance test result:
By using the composition of the present invention as experimental group, it is of the invention to just using brain rehabilitation piece as positive controls research
Normal mouse and SAMP8 presenility mouse Jumping test, the Y types water maze and influence for growing survival period, specific experiment process are as follows:
Positive drug:Piracetam Tablet (piracetam, manufacturer:Hubei Huahzong Medicine Co., Ltd, lot number:
20060812,0.4g/ pieces, people's dosage are 4.8g/kg/d)
Experimental animal:SAMP8 presenility mouse, SAMR1 normal mouses, half male and half female, 18-22g, 7 monthly ages.
Laboratory apparatus:Electronic balance (model:AL104, Mettler-Toledo Instrument (Shanghai) Co., Ltd.);Crude drug
Object isolates and purifies device (BUCHI Syncore);Mouse diving tower instrument (XZC-5Q types, Shandong Academy of Medical Sciences's maintenance of equipment supply
It stands);Y type water mazes.
Data statistics:The data of each group are represented with X ± SD, are analyzed using single factor test variance test;It is examined between two groups with t
It tests and is analyzed.
Contrast experiment one:Influence of the present invention to normal mouse and SAMP8 presenility mouse Jumping tests
The mixing powder 2g being prepared in inventive formulation one to three is respectively taken, 20 times are separately added into each mixing powder
Distilled water be made into stoste 1, stoste 2, stoste 3.
50 mouse are taken, are randomly divided into 5 groups, (10 SAMR1 mouse are just for every group of 10 animals, respectively Normal group
Normal physiological saline 40ml/kg gavages), positive drug control group (0.72g/kg gavages), control group (SAMP8 mouse normal physiologicals
Brine 40ml/kg gavages), experimental group 1 (stoste 1), experimental group 2 (stoste 2), experimental group 3 (stoste 3), with oral administration gavage in morning
Mode to mouse successive administration 20 days, the dosage gavage of 40ml/kg, once a day, the 20th day starts to train.The 1h before training
Give drug.Every batch of experiment each group has 1 mouse to be administered, operation repetitive, and so on.By first 5 mouse during training
It being respectively put into 5 grid of diving tower instrument, first adapts to environment 3min, be then electrified to, after mouse is shocked by electricity, majority jumps onto diving tower,
Escape electric shock.Copper grid are contacted to get an electric shock using mouse biped simultaneously when animal majority jumps off platform again, are considered as wrong reaction, training
5min, and electric shock number in 5min is recorded, it retests afterwards for 24 hours, is recorded and tested as observation index using incubation period and electric shock number
Achievement.
2 Jumping test result of table
Group | Training achievement (errors number) | Incubation period (second) | Performance of the test (errors number) |
Normal group (SAMR1) | 4.3±2.7** | 221.3±111.6** | 2.3±1.9** |
Positive drug control | 8.9±3.5 | 189.4±100.9* | 4.5±1.2** |
Experimental group 1 | 9.6±2.6 | 178.3±110.8* | 3.6±2.5* |
Experimental group 2 | 10.5±3.5 | 169.6±120.6* | 3.9±2.4* |
Experimental group 3 | 9.3±3.6 | 178.6±110.5* | 4.9±2.1* |
Control group | 12.5±3.7 | 150.6±120.3 | 10.9±3.8 |
* P compared with the control group<0.05, * * P compared with the control group<0.01
Experiment conclusion:
The experimental results showed that the Jumping test knot of positive drug control group, experimental group 1 (stoste 1) to experimental group 3 (stoste 3)
Fruit is than control group there were significant differences (P<0.05) ability of learning and memory for, illustrating to take mouse after the present composition improves.
The Jumping test result of experimental group 1 (stoste 1) is than positive drug control group, experimental group 2 (stoste 2), experimental group 3 (stoste 3)
It is good.
Contrast experiment two:Influence of the present invention to normal mouse and SAMP8 mouse aging Y type water maze laboratories
The mixing powder 2g being prepared in inventive formulation one to three is respectively taken, 20 times are separately added into each mixing powder
Distilled water be made into stoste 1, stoste 2, stoste 3.
50 mouse are taken, are randomly divided into 5 groups, (10 SAMR1 mouse are just for every group of 10 animals, respectively Normal group
Normal physiological saline 40ml/kg gavages), drug-positive control group (0.72g/kg gavages), control group (SAMP8 mouse normal physiologicals
Brine 40ml/kg gavages), experimental group 1 (stoste 1), experimental group 2 (stoste 2), experimental group 3 (stoste 3), with oral administration gavage in morning
Mode to mouse successive administration 20 days, the dosage gavage of 40ml/kg, once a day, the 20th day starts to train.It was administered in 20 days
1h proceeds by Y type water maze trainings afterwards.Mouse be placed on 27 ± 2 DEG C of water temperature, depth of water 10cm Y type water mazes in, side has flat
Platform arrived at platform as correct response using mouse in 15 seconds, rests 10 seconds after arrival platform and repeats training, every mouse is instructed altogether
Practice 10 times, calculate its correct response rate, it is tested after 24 hours and remembers holding situation, its memory consolidation feelings is tested after 48 hours
Condition.Using the average value of the correct response rate of 10 mouse in same group as the final result of the group, 3 are the results are shown in Table.
Table 3Y type water maze laboratory results
Group | First day correct response rate | Second day correct response rate | Third day correct response rate |
Normal group (SAMR1) | 94%** | 92%** | 95%** |
Drug-positive compares | 90%* | 91%** | 92%** |
Experimental group 1 | 87%* | 84%* | 88%* |
Experimental group 2 | 89%* | 87%* | 89%* |
Experimental group 3 | 82%* | 86%* | 85%* |
Control group | 61% | 65% | 68% |
* P compared with the control group<0.05, * * P compared with the control group<0.01
Experiment conclusion:The experimental results showed that drug-positive control group, the Y of experimental group 1 (stoste 1) to experimental group 3 (stoste 3)
Type water maze laboratory result is than control group there were significant differences (P<0.05), illustrate to take the study note of mouse after the present composition
The ability of recalling improves.The Y type water maze laboratories result of experimental group 2 (stoste 2) slightly than drug-positive control group difference but compares experimental group
1,3 (stostes 1,3) are good.
Contrast experiment three:Influence of the present invention to normal mouse and SAMP8 mouse aging survival periods
The mixing powder 2g being prepared in inventive formulation one to three is respectively taken, 20 times are separately added into the drug
Distilled water is made into stoste 1, stoste 2, stoste 3.
50 mouse are taken, are randomly divided into 5 groups, (10 SAMR1 mouse are just for every group of 10 animals, respectively Normal group
Normal physiological saline 40ml/kg gavages), drug-positive control group (0.72g/kg gavages), control group (SAMP8 mouse normal physiologicals
Brine 40ml/kg gavages), experimental group 1 (stoste 1), experimental group 2 (stoste 2), experimental group 3 (stoste 3), with the side of oral administration gavage
Formula is observed after mouse is discontinued to mouse successive administration 20 days, the dosage gavage of 40ml/kg and grows to death, record every later
The growth survival period of mouse, using the average value of the growth survival period of 10 mouse in same group as the final result of the group.
Table 4 grows survival period experimental result
Group | Growth survival period (my god) |
Normal group (SAMR1) | 98 |
Positive drug control group | 68* |
Experimental group 1 | 62** |
Experimental group 2 | 58** |
Experimental group 3 | 65** |
Control group | 49 |
* P compared with the control group<0.05, * * P compared with the control group<0.01
Experiment conclusion:The experimental results showed that positive drug control group, experimental group 1 (stoste 1) are to experimental group 3 (stoste 3)
Survival period experimental result is grown than control group there were significant differences (P<0.05), illustrating to take can be effective after the composition of the present invention
Extend the growth survival period of the mouse with senile dementia.The growth survival period experimental result of experimental group 3 (stoste 3) is than positive
Drug control group is slightly worse, but better than experimental group 1,2 (stoste 1,2).
By test above and its result it is found that the present invention composition can significantly improve the mouse with senile dementia
Learning and memory function, extend senile dementia mouse survival period, illustrate the present invention composition can restrain free radical pair
The normal operation of human body various functions, enhancing muscle power are safeguarded in the injury of cell, and Eradicates disease health cares retain youthful vitality, and energy salubrity is good for
Body, the function preventing old brain tonic, kidney tonifying enriching yin, adjust hormonal secretion, improving the elderly's physiological metabolism, enhance memory of elderly person
Brain function has senile dementia prevention and improvement result well,
The above embodiment is only the preferred embodiment of the present invention, it is impossible to the scope of protection of the invention is limited with this,
The variation and replacement for any unsubstantiality that those skilled in the art is done on the basis of the present invention belong to institute of the present invention
Claimed range.
Claims (8)
1. a kind of composition prevented or improve senile dementia, it is characterised in that:Including following raw material by weight:People
Join 2-5 parts of powder, 2-5 parts of Radix Notoginseng powder, 2-20 parts of hawthorn powder, 1-5 parts of wolfberry fruit powder, 1-5 parts of yam flour, 1-5 parts of Fructus Schisandrae Chinensis powder, Radix Polygalae
1-5 parts of powder, 0.2-4.0 parts of sorosis powder, 0.05-1.1 parts of gingko powder, 0.1-2.5 parts of kudzu-vine root powder, 0.1-2.5 parts of rhizoma alismatis powder, walnut
0.1-2.5 parts of powder, 0.2-1.6 parts of rhodiola root powder, 1-3 parts of astragalus membranaceus powder, 1-3 parts of raspberry powder, 1-3 parts of fructus alpiniae oxyphyllae powder, red date powder
5-15 parts.
2. prevention according to claim 1 or the composition of improvement senile dementia, it is characterised in that:Including below by weight
Measure the raw material of part meter:2-4 parts of ginseng pulverate, 2-3 parts of Radix Notoginseng powder, 3-16 parts of hawthorn powder, 2-5 parts of wolfberry fruit powder, 2-5 parts of yam flour, five
2-5 parts of taste powder, 2-5 parts of Radix Polygalae powder, 0.4-3.0 parts of sorosis powder, 0.05-1.5 parts of gingko powder, 0.1-2.4 parts of kudzu-vine root powder, rhizoma alismatis
0.1-2.4 parts of powder, 0.1-2.4 parts of walnut powder, 0.2-1.5 parts of rhodiola root powder, 1-2.5 parts of astragalus membranaceus powder, 1-2.5 parts of raspberry powder,
1-2.5 parts of fructus alpiniae oxyphyllae powder, 5-10 parts of red date powder.
3. prevention according to claim 1 or the composition of improvement senile dementia, it is characterised in that:Including following original
Material:Ginseng pulverate 2g, Radix Notoginseng powder 2g, hawthorn powder 8g, wolfberry fruit powder 5g, yam flour 3g, Fructus Schisandrae Chinensis powder 4g, Radix Polygalae powder 2g, sorosis powder
0.5g, gingko powder 0.06g, kudzu-vine root powder 0.2g, rhizoma alismatis powder 0.4g, walnut powder 0.4g, rhodiola root powder 0.5g, astragalus membranaceus powder 1g, basin is covered
Sub- powder 1g, fructus alpiniae oxyphyllae powder 1g, red date powder 9g.
4. prevention described in any one of claim 1 to 3 or the composition of improvement senile dementia, it is characterised in that:
The ginseng pulverate is the powder or its extract of wild ginseng, artificial growth ginseng, Korean ginseng or American Ginseng.
5. prevention described in any one of claim 1 to 3 or the composition of improvement senile dementia, it is characterised in that:
Trace element is further included, the trace element is magnesium, zinc, selenium, is respectively in the content of composition:0.01~0.5mg/g of magnesium,
0.01~0.2mg/g of zinc, 0.01~0.5mg/g of selenium.
6. prevention according to claim 5 or the composition of improvement senile dementia, it is characterised in that:The magnesium is tristearin
Sour magnesium, the zinc are one kind in zinc sulfate, zinc citrate, zinc lactate, glycine zine or zinc gluconate;The selenium is selected from
One kind in sodium selenite, selenoprotein or Se-enriched yeast.
7. the medicine that composition according to any one of claims 1 to 3 has the function of to prevent or improve senile dementia in preparation
Application in product, health products, food.
8. application according to claim 7, it is characterised in that:The drug for capsule, tablet, pulvis, granule or
One kind in pill;The health products are one kind in solid beverage, tea bag, oral liquid or health liquor;The food for cake,
One kind in biscuit, candy, Yoghourt, hawthorn item, jelly or mixed congee.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810252992.5A CN108186966A (en) | 2018-03-26 | 2018-03-26 | A kind of composition for preventing or improving senile dementia and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810252992.5A CN108186966A (en) | 2018-03-26 | 2018-03-26 | A kind of composition for preventing or improving senile dementia and its application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108186966A true CN108186966A (en) | 2018-06-22 |
Family
ID=62596182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810252992.5A Pending CN108186966A (en) | 2018-03-26 | 2018-03-26 | A kind of composition for preventing or improving senile dementia and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108186966A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109463725A (en) * | 2018-11-01 | 2019-03-15 | 云南香绿源科技开发有限公司 | It is a kind of to have effects that purify the functional food and preparation method thereof of blood |
WO2021031536A1 (en) * | 2019-08-20 | 2021-02-25 | 泓博元生命科技(深圳)有限公司 | Use of nadh and/or nmn in preparing medicaments and health care products for brain function recovery |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017104706A1 (en) * | 2015-12-18 | 2017-06-22 | 国立大学法人 富山大学 | Agent and composition for inducing expression of brain-derived neurotrophic factor |
CN107432473A (en) * | 2017-09-21 | 2017-12-05 | 珠海霍普金斯医药研究院股份有限公司 | A kind of functional food for being used to prevent senile dementia |
-
2018
- 2018-03-26 CN CN201810252992.5A patent/CN108186966A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017104706A1 (en) * | 2015-12-18 | 2017-06-22 | 国立大学法人 富山大学 | Agent and composition for inducing expression of brain-derived neurotrophic factor |
CN107432473A (en) * | 2017-09-21 | 2017-12-05 | 珠海霍普金斯医药研究院股份有限公司 | A kind of functional food for being used to prevent senile dementia |
Non-Patent Citations (4)
Title |
---|
戴恩来: "《中医临床学I》", 30 June 2014, 甘肃科学技术出版社 * |
梁纪文等: "老年性痴呆的中医辨证及中成药应用", 《中国临床医生》 * |
石景洋等: ""治疗老年痴呆病中药应用频次及临床分析"", 《中国实验方剂学杂志》 * |
蓝统胜等: "《微量元素防病指南》", 28 February 2015, 华南理工大学出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109463725A (en) * | 2018-11-01 | 2019-03-15 | 云南香绿源科技开发有限公司 | It is a kind of to have effects that purify the functional food and preparation method thereof of blood |
WO2021031536A1 (en) * | 2019-08-20 | 2021-02-25 | 泓博元生命科技(深圳)有限公司 | Use of nadh and/or nmn in preparing medicaments and health care products for brain function recovery |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (en) | Health food for preventing diabetes | |
CN103719498B (en) | A kind of Siberian solomonseal rhizome health-care tea improving immunity and preparation method thereof | |
CN102907604B (en) | Health-care product having effects of reducing blood sugar and pressure, losing weight, relaxing bowels, maintaining beauty and resisting fatigue and production process thereof | |
CN103416760B (en) | Whole-grain total-nutrition formulation food for treating and preventing sarcopenia | |
CN101253903B (en) | Health food with fat-reducing function and its preparation | |
CN102172269B (en) | Hidegelatin fabricated food with beautification function | |
CN103007146B (en) | Healthcare nutrition powder for enhancing memory ability | |
CN106266700A (en) | A kind of Fructus Hippophae prescription bag alveolitoid medicinal tea allotment and manufacture method | |
CN101579120A (en) | Nutritional food with weight-losing function and preparation method thereof | |
CN105695258A (en) | Female health wine containing lychee seed saponin | |
CN103859379A (en) | Formula and preparation method of life cultivation and health preservation food helpful for improving memory | |
CN103719497A (en) | Gynostemma pentaphylla fat-reducing and weight-losing health-care tea and preparation method thereof | |
CN105454576A (en) | Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof | |
CN106177183A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, green tea and Folium Mori | |
CN106937741A (en) | A kind of degreasing linseed meal cancer-resisting health slimming method and preparation method thereof | |
CN106177053A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja and Pericarpium Citri Reticulatae | |
CN101711840B (en) | Medicine-food dual-purpose composition suitable for cancerous patients and preparation method thereof | |
CN104223297B (en) | A kind of schisandra chinensis health-care oral liquid of slow down aging and preparation method thereof | |
CN106177477A (en) | A kind of health composition for blood sugar lowering, blood fat reducing and blood pressure lowering | |
CN108186966A (en) | A kind of composition for preventing or improving senile dementia and its application | |
CN106177432A (en) | A kind of health composition comprising leaf of Cyclocarya paliurus Iljinskaja, Folium Mori, green tea and Rhizoma Polygonati Odorati | |
CN104206595A (en) | Blood lipid and blood glucose reducing Chinese wolfberry root-bark health care tea and preparation method thereof | |
CN104489172A (en) | Acanthopanax health tea for improving immunity and preparation method thereof | |
CN106173605A (en) | A kind of Hyperglycemic health care compositions comprising Radix Puerariae and Herba Dendrobii | |
CN104544084B (en) | A kind of health food for diabetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180622 |
|
RJ01 | Rejection of invention patent application after publication |